Skip to main content
Caplight Logo









Nanolive SA

Nanolive SA

Private
SwitzerlandHealthcare & Life Scienceshttps://www.nanolive.com/

Last Round

Series C

Sep 21, 2022

Total Funding Raised

$25M

Company Overview

Nanolive SA is a biotechnology company that develops and commercializes label-free, non-invasive live cell imaging and analysis platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Imaging, Drug Discovery, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

label-free imaginglive cell imagingholographic tomography3D cell imaginglive cell microscopedrug discoverycell therapycell analysis softwarehigh-content imagingphenotypic screeningimmuno-oncologyquantitative cell analysisautomated cell imagingdigital assaybiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanolive SA Comparables

Compare Nanolive SA with similar companies based on industry and business-model similarity.

Nanolive SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tomocube Inc.
87%
Interherence GmbH
81%
Bruker
78%

Nanolive SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CSep 21, 2022
SeedNov 4, 2014

Key People

Founding team and executive leadership

Yann Cotte

CEO & Co-founder

Founding Team

Nanolive SA Investors

Notable investors and investment history

Nanolive SA investors
InvestorRounds
Taiwania CapitalSeries C
Swisscom VenturesSeries C
InnovivaSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 21, 2022

    $22M round led by Innoviva and Taiwania Capital.

  • Nov 4, 2014

    $3M raised in Seed round.

Nanolive SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanolive SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanolive SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersSwitzerland
Employee Range33
Year Founded2013
Last FundingSep 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?